ABCB1 and cancer: Doxorubicin is a substrate for MDR1 transporter (Abolhoda et al., 1999), and a positive correlation between MDR1 expression and doxorubicin resistance in human cancer cell lines has been shown, previously (Mechetner et al., 1998).